The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: The iBRA-2 Study

Published on Apr 30, 2019in British Journal of Cancer5.791
· DOI :10.1038/S41416-019-0438-1
Rachel O'Connell9
Estimated H-index: 9
(The Royal Marsden NHS Foundation Trust),
Tim Rattay9
Estimated H-index: 9
(University of Leicester)
+ 7 AuthorsChris Holcombe14
Estimated H-index: 14
Immediate breast reconstruction (IBR) is routinely offered to improve quality-of-life for women requiring mastectomy, but there are concerns that more complex surgery may delay adjuvant oncological treatments and compromise long-term outcomes. High-quality evidence is lacking. The iBRA-2 study aimed to investigate the impact of IBR on time to adjuvant therapy. Consecutive women undergoing mastectomy ± IBR for breast cancer July–December, 2016 were included. Patient demographics, operative, oncological and complication data were collected. Time from last definitive cancer surgery to first adjuvant treatment for patients undergoing mastectomy ± IBR were compared and risk factors associated with delays explored. A total of 2540 patients were recruited from 76 centres; 1008 (39.7%) underwent IBR (implant-only [n = 675, 26.6%]; pedicled flaps [n = 105,4.1%] and free-flaps [n = 228, 8.9%]). Complications requiring re-admission or re-operation were significantly more common in patients undergoing IBR than those receiving mastectomy. Adjuvant chemotherapy or radiotherapy was required by 1235 (48.6%) patients. No clinically significant differences were seen in time to adjuvant therapy between patient groups but major complications irrespective of surgery received were significantly associated with treatment delays. IBR does not result in clinically significant delays to adjuvant therapy, but post-operative complications are associated with treatment delays. Strategies to minimise complications, including careful patient selection, are required to improve outcomes for patients.
📖 Papers frequently viewed together
17 Citations
17 Citations
#1Shelley Potter (UoB: University of Bristol)H-Index: 17
#2Elizabeth J Conroy (University of Liverpool)H-Index: 11
Last. D ZhengH-Index: 1
view all 14 authors...
Summary Background Use of biological or synthetic mesh might improve outcomes of immediate implant-based breast reconstruction—breast reconstruction with implants or expanders at the time of mastectomy—but there is a lack of high-quality evidence to support the safety or effectiveness of the technique. We aimed to establish the short-term safety of immediate implant-based breast reconstruction performed with and without mesh, to inform the feasibility of undertaking a future randomised clinical ...
45 CitationsSource
#1Pietro G. di Summa (Glasgow Royal Infirmary)H-Index: 13
#2Sherylin K. Tay (Glasgow Royal Infirmary)H-Index: 2
Last. Russell J. Bramhall (Glasgow Royal Infirmary)H-Index: 3
view all 5 authors...
1 CitationsSource
#1Luis Riba (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 5
#2Ryan A. Gruner (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 6
Last. Ted A. James (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 18
view all 4 authors...
Background Timely administration of adjuvant chemotherapy for breast cancer is associated with a survival benefit. Specific elements of surgical management may lead to delays initiating chemotherapy, resulting in unfavorable outcomes. The purpose of this study was to determine the correlation between surgical factors and delayed chemotherapy in breast cancer patients.
11 CitationsSource
#1Edwin G. WilkinsH-Index: 45
#2Jennifer B. Hamill (UM: University of Michigan)H-Index: 22
Last. Andrea L. Pusic (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 81
view all 7 authors...
Objective: In postmastectomy reconstruction, procedure choice is heavily influenced by the relative risks of the various options. This study sought to evaluate complications in a large, multicenter patient population. Summary of Background Data: Previous studies have reported widely varying complication rates, but have been limited by their single center designs and inadequate controlling for confounders in their analyses. Methods: Eleven sites enrolled women undergoing first time, immediate, or...
68 CitationsSource
#1Alice Y. Ho (Cedars-Sinai Medical Center)H-Index: 29
#2Zishuo I. Hu (Mount Sinai Health System)H-Index: 5
Last. Edwin G. Wilkins (UM: University of Michigan)H-Index: 45
view all 4 authors...
Summary As the use of breast reconstruction and postmastectomy radiotherapy (PMRT) has increased over the past decade, the typical approach to integrating radiotherapy with breast reconstruction has provoked intense controversy in the management of breast cancer. PMRT can lead to an increased frequency of complications in the reconstructed breast. Conversely, the reconstructed breast can increase the complexity of radiotherapy delivery. How to minimise the frequency of complications without comp...
52 CitationsSource
Postmastectomy breast reconstruction (PMBR) is an elective, preference-sensitive decision made during a stressful, time-pressured period after a cancer diagnosis. Shared decision making (SDM) can improve decision quality about preference-sensitive choices. Stakeholders’ perspectives on ways to support PMBR decision-making were explored. Forty semi-structured interviews with stakeholders (20 postmastectomy patients, 10 PMBR surgeons, 10 PMBR nurses) were conducted. Clinicians were recruited from ...
11 CitationsSource
#1Senthurun Mylvaganam (New Cross Hospital)H-Index: 4
#2Elizabeth J Conroy (University of Liverpool)H-Index: 11
Last. Joe D. PiperH-Index: 8
view all 153 authors...
Abstract Introduction The introduction of biological and synthetic meshes has revolutionised the practice of implant-based breast reconstruction (IBBR) but evidence for effectiveness is lacking. The iBRA (implant Breast Reconstruction evAluation) study is a national trainee-led project that aims to explore the practice and outcomes of IBBR to inform the design of a future trial. We report the results of the iBRA National Practice Questionnaire (NPQ) which aimed to comprehensively describe the pr...
14 CitationsSource
#1John Browne (UCC: University College Cork)H-Index: 50
#2Ranjeet Jeevan (RCS: Royal College of Surgeons of England)H-Index: 13
Last. Jan van der Meulen (Lond: University of London)H-Index: 61
view all 6 authors...
BACKGROUND Medical treatment for breast cancer is associated with substantial toxicity and patient burden. There is less known about the impact of surgical complications. Understanding this impact could provide important information for patients when they are considering surgical options. METHODS Between 2008 and 2009, the UK National Mastectomy and Breast Reconstruction Audit recorded surgical complications for a prospective cohort of 17,844 women treated for breast cancer at 270 hospitals; 640...
19 CitationsSource
#1Nicole Ilonzo (Mount Sinai Hospital)H-Index: 7
#2Ashley Tsang (Mount Sinai Hospital)H-Index: 1
Last. Aye Moe Thu Ma (Mount Sinai Hospital)H-Index: 2
view all 5 authors...
Abstract The landscape of breast reconstruction has changed significantly. This study assesses trends in type of reconstruction performed after mastectomy and impact on immediate postoperative complications. Methods Data for 67,450 patients undergoing mastectomy for breast cancer were analyzed using the National Surgical Quality Improvement Program (NSQIP) database for years 2005-2014. Primary outcomes were wound, nonwound related infections, and bleeding complications. Data were analyzed by uni...
63 CitationsSource
#1Giuseppe CuriglianoH-Index: 74
#2Carmen CriscitielloH-Index: 29
Last. Giancarlo Pruneri (University of Milan)H-Index: 76
view all 4 authors...
Abstract Avoidance of unnecessary or ineffective treatment should be one of the main goals in adjuvant breast oncology today. Unfortunately, both patients and doctors hunt for tiny statistical differences in survival curves. This search could not only lead to an oncological approach of unlimited addition that we will not be able to afford, but would also end inevitably in indeterminate overtreatment with substantial risks of unexpected toxic effects eating away whatever progress we might make. “...
9 CitationsSource
Cited By13
Introduction null Therapeutic mammaplasty (TM) is an oncological procedure which combines tumour resection with breast reduction and mastopexy techniques. Previous systematic reviews have demonstrated oncological safety of TM, but poor and inconsistent reporting of quality-of-life, aesthetic and functional outcomes, often with non-validated measurement tools. Moreover, there is a paucity of patient-reported outcome measures. Standardisation of outcome reporting is required to enable study result...
#1Lisa Whisker (NUH: Nottingham University Hospitals NHS Trust)H-Index: 8
#2Matthew Barber (Western General Hospital)H-Index: 8
Last. Shelley Potter (North Bristol NHS Trust)H-Index: 17
view all 9 authors...
These guidelines have been produced with the involvement of the Association of Breast Surgery and the British Association of Plastic, Reconstructive and Aesthetic Surgeons. Recommendations have been derived after a review of published data regarding the use of acellular dermal matrix (ADM), biological and synthetic mesh in breast reconstruction. The guidelines represent a consensus opinion on the optimal management of patients having biological or synthetic mesh assisted breast reconstruction in...
#1Adam Gilmour (Glasgow Royal Infirmary)H-Index: 2
#2Ramsey I. Cutress (University of Southampton)H-Index: 26
Last. Jacqueline ChurchH-Index: 1
view all 16 authors...
Oncoplastic Breast Surgery has become standard of care in the management of Breast. Cancer Patents. These guidelines written by an Expert Advisory Group; convened by the Association of Breast Surgery (ABS) and the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), are designed to provide all members of the breast cancer multidisciplinary team (MDT) with guidance on the best breast surgical oncoplastic and reconstructive practice at each stage of a patient's journey, ...
104 CitationsSource
#1Charlotte F Davies (UoB: University of Bristol)H-Index: 11
#2Christopher Holcombe (University of Liverpool)H-Index: 19
Last. Shelley Potter (UoB: University of Bristol)H-Index: 17
view all 12 authors...
Introduction Approximately 40% of the 55 000 women diagnosed with breast cancer each year in the UK undergo mastectomy because they are considered unsuitable for standard breast-conserving surgery (BCS) due to tumour size or multiple tumour foci. Mastectomy can significantly impact women’s quality of life, and only one in four women currently undergo immediate breast reconstruction (IBR). Level 2 oncoplastic breast-conserving surgery (OPBCS) combines removing the cancer with a range of plastic s...
#1J Murphy (University of Manchester)H-Index: 2
Last. Richard Searle (Smith & Nephew)H-Index: 7
view all 4 authors...
Background Single-use negative-pressure wound therapy (sNPWT) has been reported to reduce the incidence of reconstruction failure in prepectoral breast reconstruction compared with standard surgical dressings. The aim of this economic evaluation was to investigate the cost-effectiveness of sNPWT compared with standard care for the prevention of reconstruction failure in prepectoral breast reconstruction in the UK. Method A decision tree model was used to estimate the expected cost and effectiven...
#1Fak Mazari (University Hospital Southampton NHS Foundation Trust)H-Index: 1
#2Ghulam WattooH-Index: 1
Last. Iman Azmy (Chesterfield Royal Hospital NHS Foundation Trust)H-Index: 5
view all 7 authors...
BACKGROUND Prophylactic antibiotics are used in acellular dermal matrix-assisted implant-based breast reconstructions. However, there are no universally accepted guidelines regarding the best regimen. This retrospective, multicentre study was designed to compare the different prophylactic antibiotic regimens in these patients in three hospitals across two NHS trusts over a five-year period. METHODS Case notes and electronic records were reviewed for all patients undergoing acellular dermal matri...
#1Giovanni Papa (UniTS: University of Trieste)H-Index: 9
#2Andrea Frasca (UniTS: University of Trieste)
Last. Zoran Marij Arnež (UniTS: University of Trieste)H-Index: 7
view all 7 authors...
Surgical site infection in implant-based breast reconstruction is a complication with variable incidence reported in the literature. Due to potential loss of implant and reconstruction, it can have a strong psychological impact on patients. Background and objectives: This study aimed primarily at analyzing the current status of the surgical site infection (SSI), (type, time of onset, clinical presentation, pathogens and management) in patients who underwent implant-based breast reconstruction at...
#1Zeren Shen (ZJU: Zhejiang University)H-Index: 4
#2Jiaqi Sun (ZJU: Zhejiang University)H-Index: 5
Last. Jinghong Xu (ZJU: Zhejiang University)H-Index: 8
view all 7 authors...
Summary Background Currently, breast cancer patients undergoing mastectomy (MA) have three surgical options: MA only and reconstruction at the time of MA ("immediate," IBR) or at a later time ("delayed," DBR). To assess the oncological safety and complication risks associated with different surgical choices, a systematic review with Bayesian network analysis was conducted. Methods Cochrane library, PubMed/MEDLINE, EMBASE, and the China National Knowledge Infrastructure were systematically search...
4 CitationsSource
#1Nicola RoccoH-Index: 13
#2Giacomo Montagna (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 6
Last. Giuseppe CatanutoH-Index: 16
view all 19 authors...
INTRODUCTION: The rapid spread of COVID-19 across the globe is forcing surgical oncologists to change their daily practice. We sought to evaluate how breast surgeons are adapting their surgical activity to limit viral spread and spare hospital resources. METHODS: A panel of 12 breast surgeons from the most affected regions of the world convened a virtual meeting on April 7, 2020, to discuss the changes in their local surgical practice during the COVID-19 pandemic. Similarly, a Web-based poll bas...
5 CitationsSource
#1Uhi Toh (Kurume University)H-Index: 18
#2Miki Takenaka (Kurume University)H-Index: 8
Last. Yoshito Akagi (Kurume University)H-Index: 27
view all 4 authors...
Advances in multi-modality treatments incorporating systemic chemotherapy, endocrine therapy, and radiotherapy for the management of breast cancer have resulted in a surgical-management paradigm change toward less-aggressive surgery that combines the use of breast-conserving or -reconstruction therapy as a new standard of care with a higher emphasis on cosmesis. The implementation of skin-sparing and nipple-sparing mastectomies (SSM, NSM) has been shown to be oncologically safe, and breast recon...